细胞外囊泡和缺血性心血管疾病
Yujiao Zhu1, Siqi Wang1, Xuerui Chen2
1Cardiac Regeneration and Ageing Lab, Institute of Cardiovascular Sciences, Shanghai Engineering Research Center of Organ Repair, School of Life Science, Shanghai University, Shanghai, China.
Advances in experimental medicine and biology
|August 21, 2023
概括
细胞外囊泡 (EVs) 显示出治疗缺血性心血管疾病的前景,并作为生物标志物. 基于EV的疗法为心脏修复提供了细胞移植的生物相容替代方案.
科学领域:
- 心血管生物学 心血管生物学
- 再生医学是一种再生医学.
- 生物技术是生物技术.
背景情况:
- 缺血性心血管疾病,标志着冠状动脉阻塞,可以导致严重的心脏损伤.
- 细胞外囊泡 (EVs) 对于细胞间通信和细胞调节至关重要.
- 目前的干细胞治疗等治疗方法面临着诸如瘤性和免疫性等挑战.
研究的目的:
- 要总结本地和工程电动汽车的心脏保护作用.
- 探索电动汽车作为缺血性心血管疾病生物标志物的潜力.
- 突出基于EV的治疗作为心脏修复的再生策略.
主要方法:
- 对心血管环境中的细胞外囊泡现有文献的综述.
- 分析了详细介绍不同细胞类型EVs组成和功能的研究.
- 评估EV在缺血性心脏病中的诊断和治疗应用.
主要成果:
- EVs促进了涉及心脏平衡和疾病病理生理学的近信号传递.
- 来自各种细胞 (干细胞,心肌细胞等) 的原生和生物工程EV. 显示出心脏保护功能.
- 循环的EV可以作为非侵入性生物标志物,用于早期临床诊断缺血性心血管疾病.
结论:
- 电动汽车代表了一种有希望的无细胞治疗方法,用于心脏修复和再生.
- 电动汽车为直接基于细胞的疗法提供了一个生物相容和潜在的更安全的替代方案.
- 作为缺血性心血管疾病的生物标志物,EVs的诊断潜力是显著的.
相关概念视频
Ischemic Heart Disease: Overview
1.3K
Ischemic heart disease occurs when the heart's blood supply dwindles, causing an ominous lack of oxygen and nutrients. This deficiency, stemming from reduced or obstructed blood flow, spells danger, leading to heart muscle damage and dysfunction.
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
Atherosclerosis, the primary malefactor, orchestrates this dangerous condition. It manifests as the accumulation of fatty deposits, akin to insidious plaques, within arterial walls. As time elapses, these plaques metamorphose, hardening and...
1.3K
Overview of Exosomes
2.7K
Exosomes are stable, lipid bilayer-enclosed vesicles capable of crossing biological barriers. They can carry a wide range of molecules required for intercellular communication. Once exosomes are released from the cell where they originated, they enter a recipient cell through various pathways such as fusion, receptor-mediated endocytosis, macropinocytosis, and phagocytosis.
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
2.7K
Coronary Artery Disease II: Pathophysiology
12
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
12
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations
20
The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
20
Cardiovascular Drugs: Classification based on Therapeutic Indications
2.9K
Cardiovascular diseases, encompassing a range of conditions, can significantly affect the heart's operations and the overall circulatory system. These conditions impair the heart's ability to pump blood, leading to a deficit in oxygen supply to crucial organs. Anomalies in the heart's electrical system, known as arrhythmias, can cause heartbeats to accelerate or slow down. Usually, heart rates increase during physical activity and decrease while resting or sleeping. However,...
2.9K
Intralumenal Vesicles and Multivesicular Bodies
3.6K
Intraluminal vesicles (ILVs) are small vesicles 50-80 nm in diameter formed during the maturation of early endosomes. A specialized endosome containing numerous ILVs is called a multivesicular body (MVB). ILVs contain internalized molecules such as antigens, nucleic acids, proteins, and metabolites. Some of these molecules are released from the MVBs inside exosomes and are transported to other cells. Other MVBs contain molecules that are retained in the ILVs and are later degraded within the...
3.6K


